Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Innocoll Holdings PLC (NASDAQ:INNL) Share Price

News coverage about Innocoll Holdings PLC (NASDAQ:INNL) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innocoll Holdings PLC earned a media sentiment score of 0.25 on Accern’s scale. Accern also gave headlines about the specialty pharmaceutical company an impact score of 44.935098488535 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Shares of Innocoll Holdings PLC (NASDAQ INNL) remained flat at $2.35 during midday trading on Friday. 392,951 shares of the company were exchanged. Innocoll Holdings PLC has a 52-week low of $0.53 and a 52-week high of $6.51. The firm has a 50-day moving average of $2.25 and a 200 day moving average of $1.58.

A number of equities research analysts have recently weighed in on the company. FBR & Co restated a “hold” rating on shares of Innocoll Holdings PLC in a research note on Tuesday, July 4th. Zacks Investment Research lowered Innocoll Holdings PLC from a “hold” rating to a “sell” rating in a research note on Tuesday, May 16th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $3.75.

COPYRIGHT VIOLATION WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Innocoll Holdings PLC (NASDAQ:INNL) Share Price” was posted by Rincon Hill News and is the sole property of of Rincon Hill News. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at

About Innocoll Holdings PLC

Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.

Insider Buying and Selling by Quarter for Innocoll Holdings PLC (NASDAQ:INNL)

Receive News & Ratings for Innocoll Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll Holdings PLC and related companies with our FREE daily email newsletter.


Latest News

Leave a Reply

© 2006-2017 Rincon Hill News.